Recent Research | Page 10 | Aplastic Anemia and MDS International Foundation

Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Title Original Publication Datesort ascending Journal Bone Marrow Disease
Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher risk myelodysplastic syndromes Jan 2017 Cancer myelodysplastic syndromes (MDS)
How I treat acquired aplastic anemia Jan 2017 Blood aplastic anemia
Hypomethylating agents in combination with histone deacetylase inhibitors in higher risk myelodysplastic syndromes: Is there a light at the end of the tunnel? Jan 2017 Cancer myelodysplastic syndromes (MDS)
MicroRNAs and tRNA-derived fragments predict the transformation of myelodysplastic syndromes to acute myeloid leukemia Jan 2017 Leuk Lymphoma myelodysplastic syndromes (MDS)
Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia Jan 2017 Int J Hematol aplastic anemia
Impact of Achievement of Complete Cytogenetic Response on Outcome in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agents Jan 2017 Am J Hematol myelodysplastic syndromes (MDS)
Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results Jan 2017 Bone Marrow Transplant aplastic anemia
Decision points in the treatment of transfusional iron overload in patients with myelodysplastic syndromes: why, when, and how to chelate Jan 2017 Expert Rev Hematol myelodysplastic syndromes (MDS)
Aplastic anemia and risk of deep vein thrombosis and pulmonary embolism: A nationwide cohort study Jan 2017 Thromb Res aplastic anemia
Searching for a Light at the End of the Tunnel? Beyond Hypomethylating Agents in Myelodysplastic Syndromes. Jan 2017 Am Soc Clin Oncol Educ Book myelodysplastic syndromes (MDS)